+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446134
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Elsevier B.V.
  • Macmillan
  • McKesson Corporation
  • Philips Healthcare
  • Siemens Healthineers
Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global cancer clinical decision tools market.



This report focuses on the cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the cancer clinical decision tools market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for cancer clinical decision tools? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cancer Clinical Decision Tools market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider cancer clinical decision tools market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer clinical decision tools market section of the report gives context. It compares the cancer clinical decision tools market with other segments of the cancer clinical decision tools market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer clinical decision tools indicators comparison.

Scope


Markets Covered:

  • By Type: Risk Assessment Tool(RAT); Qcancer
  • By End-User: Hospital; Clinics

Companies Mentioned:


McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Elsevier B.V.; Siemens Healthineers

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Cancer Clinical Decision Tools Market

What is the estimated value of the Global Cancer Clinical Decision Tools Market?

The Global Cancer Clinical Decision Tools Market was estimated to be valued at €0.40 billion in 2021.

What is the growth rate of the Global Cancer Clinical Decision Tools Market?

The growth rate of the Global Cancer Clinical Decision Tools Market is 9.0%, with an estimated value of €0.60 billion by 2025.

What is the forecasted size of the Global Cancer Clinical Decision Tools Market?

The Global Cancer Clinical Decision Tools Market is estimated to be worth €0.60 billion by 2025.

Who are the key companies in the Global Cancer Clinical Decision Tools Market?

Key companies in the Global Cancer Clinical Decision Tools Market include McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers, Elsevier B.V. and National Decision Support Company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Elsevier B.V.
  • Macmillan
  • McKesson Corporation
  • Philips Healthcare
  • Siemens Healthineers
1. Executive Summary

2. Cancer Clinical Decision Tools Market Characteristics

3. Cancer Clinical Decision Tools Market Trends and Strategies

4. Impact Of COVID-19 On Cancer Clinical Decision Tools

5. Cancer Clinical Decision Tools Market Size and Growth
5.1. Global Cancer Clinical Decision Tools Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Cancer Clinical Decision Tools Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market

6. Cancer Clinical Decision Tools Market Segmentation
6.1. Global Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Risk Assessment Tool(RAT)
  • Qcancer
6.2. Global Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Clinics
7. Cancer Clinical Decision Tools Market Regional and Country Analysis
7.1. Global Cancer Clinical Decision Tools Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Cancer Clinical Decision Tools Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cancer Clinical Decision Tools Market
8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cancer Clinical Decision Tools Market
9.1. China Cancer Clinical Decision Tools Market Overview
9.2. China Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cancer Clinical Decision Tools Market
10.1. India Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cancer Clinical Decision Tools Market
11.1. Japan Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cancer Clinical Decision Tools Market
12.1. Australia Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cancer Clinical Decision Tools Market
13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cancer Clinical Decision Tools Market
14.1. South Korea Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cancer Clinical Decision Tools Market
15.1. Western Europe Cancer Clinical Decision Tools Market Overview
15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cancer Clinical Decision Tools Market
16.1. UK Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cancer Clinical Decision Tools Market
17.1. Germany Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cancer Clinical Decision Tools Market
18.4. France Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cancer Clinical Decision Tools Market
19.1. Eastern Europe Cancer Clinical Decision Tools Market Overview
19.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cancer Clinical Decision Tools Market
20.1. Russia Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cancer Clinical Decision Tools Market
21.1. North America Cancer Clinical Decision Tools Market Overview
21.2. North America Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cancer Clinical Decision Tools Market
22.1. USA Cancer Clinical Decision Tools Market Overview
22.2. USA Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cancer Clinical Decision Tools Market
23.1. South America Cancer Clinical Decision Tools Market Overview
23.2. South America Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cancer Clinical Decision Tools Market
24.1. Brazil Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cancer Clinical Decision Tools Market
25.1. Middle East Cancer Clinical Decision Tools Market Overview
25.2. Middle East Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cancer Clinical Decision Tools Market
26.1. Africa Cancer Clinical Decision Tools Market Overview
26.2. Africa Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cancer Clinical Decision Tools Market Competitive Landscape and Company Profiles
27.1. Cancer Clinical Decision Tools Market Competitive Landscape
27.2. Cancer Clinical Decision Tools Market Company Profiles
27.2.1. McKesson Corporation
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Medical Information Technology Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Philips Healthcare
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Elsevier B.V.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Siemens Healthineers
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers and Acquisitions in the Cancer Clinical Decision Tools Market

29. Cancer Clinical Decision Tools Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Elsevier B.V.
  • Macmillan
  • McKesson Corporation
  • Philips Healthcare
  • Siemens Healthineers
Major players in the cancer clinical decision tools market are McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers, Elsevier B.V., Macmillan, and National Decision Support Company.

The global cancer clinical decision tools market is expected to grow from $0.36 billion in 2020 to $0.39 billion in 2021 at a compound annual growth rate (CAGR) of 8.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $0.55 billion in 2025 at a CAGR of 9%.

The cancer clinical decision tools market consists of sales of cancer decision support tools and related services. Cancer decision tools are designed to support the general practitioner's assessment of patients with potential cancer symptoms. The tools do not change the clinical judgment but give more information that is used to inform patient management decisions. The risk is measured based on reading coded information from the patient record including demographic data, medical history, and symptoms.

The cancer clinical decision tools market covered in this report is segmented by type into risk assessment tool (RAT), Qcancer and by end-user into hospitals, clinics.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The breach of data and privacy of patients is a major challenge in the cancer clinical decision tools market. Hackers can get access to data centers through healthcare employee’s emails leading to a breach of patients' information privacy. For instance, in 2019, the Regional Cancer Care Association (RCCA) reported a data breach through phishing email attempts. Email phishing is a primary attack because it is not detectable by email security tools, out of 15 million patient records breached, 11.4 million records were caused by phishing attacks. The risk of the loss of data and privacy of patients harms the growth of the cancer clinical decision tools market.

In January 2019, Qiagen, a Germany based provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research acquired N-of-One for an undisclosed amount. The acquisition of N-of-One will enable QIAGEN to significantly expand its decision-support solutions while offering a broader range of software, content and service-based solutions. It will also enable QIAGEN to expand its clinical bioinformatics capabilities in molecular oncology decision support. N-of-One, a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision tools market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the market growth.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • McKesson Corporation
  • Medical Information Technology Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • Elsevier B.V.
  • Macmillan
  • National Decision Support Company
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll